FAAH and migraine disorder: More specifically, we evaluated the effect of JZL195, an FAAH/MAGL inhibitor, on (i) NTG-induced trigeminal hyperalgesia at the orofacial formalin test; (ii) anxiety-like behavior and spontaneous locomotor activity; and (iii) molecular mediators of the potential JZL195 anti-migraine effect.